Effects of Switching from Agalsidase Beta to Agalsidase Alfa in 10 Patients with Anderson-Fabry Disease

Anderson-Fabry disease (AFD) is a multiorgan X-linked lysosomal storage disease that particularly affects the heart, kidneys, and cerebrovascular system. Current treatment is enzyme replacement therapy (ERT) with agalsidase beta (Fabrazyme(®), Genzyme Corporation, Cambridge, MA, USA) or agalsidase a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Pisani, A., Spinelli, L., Visciano, B., Capuano, I., Sabbatini, M., Riccio, E., Messalli, G., Imbriaco, M.
Format: Artigo
Sprog:Inglês
Udgivet: Springer Berlin Heidelberg 2012
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3565648/
https://ncbi.nlm.nih.gov/pubmed/23430546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2012_177
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker